SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-138376
Filing Date
2019-05-06
Accepted
2019-05-06 16:47:00
Documents
62
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d632416d10q.htm 10-Q 393291
2 EX-31.1 d632416dex311.htm EX-31.1 6610
3 EX-31.2 d632416dex312.htm EX-31.2 6646
4 EX-32.1 d632416dex321.htm EX-32.1 3141
5 EX-32.2 d632416dex322.htm EX-32.2 3195
  Complete submission text file 0001193125-19-138376.txt   2890900

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bdsi-20190331.xml EX-101.INS 458485
7 XBRL TAXONOMY EXTENSION SCHEMA bdsi-20190331.xsd EX-101.SCH 40169
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdsi-20190331_cal.xml EX-101.CAL 58763
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdsi-20190331_def.xml EX-101.DEF 131892
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsi-20190331_lab.xml EX-101.LAB 315564
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsi-20190331_pre.xml EX-101.PRE 225611
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Filer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31361 | Film No.: 19799915
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences